Findings of a phase 2 trial with aldosteron synthase inhibitor in hypertension - PACE-CME

Findings of a phase trial with aldosteron synthase inhibitor in hypertension

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Imaging study with PCSK9 inhibitor in patients with stable CAD
Imaging study with PCSK9 inhibitor in patients with stable CAD
ACC.23
Imaging study with PCSK9 inhibitor in patients with stable CAD
- Annapoorna Kini, MD
A wearable device using infrared spectrophotometry to detect troponin I
A wearable device using infrared spectrophotometry to detect troponin I
ACC.23
A wearable device using infrared spectrophotometry to detect troponin I
- Prof. Partho Sengupta, MD
Do personalized reminders to clinicians result in higher use of high-intensity statins?
Do personalized reminders to clinicians result in higher use of high-intensity statins?
ACC.23
Do personalized reminders to clinicians result in higher use of high-intensity statins?
- Prof. Salim Virani, MD, PhD
Promising results for oral PCSK9i to proceed to phase 3 trials
Promising results for oral PCSK9i to proceed to phase 3 trials
ACC.23
Promising results for oral PCSK9i to proceed to phase 3 trials
- Christie Ballantyne, MD